-
Antibody-drug conjugates
New and promising trends in therapeutic ADC generation
With the growth of the global market for therapeutic antibody-drug conjugates (ADCs), researchers are set on developing exciting new technologies. In the next decades, we will likely witness significant…
-
CAR-T cell therapy
From the first to the fifth generation of CAR-T cells
Read more -
Antibody-drug conjugates
Robust methods for the detailed analysis of drug-to-antibody ratio (DAR) and drug load distribution
Read more -
CAR-T cell therapy
The structure of CAR-T cells
Read more -
Antibody-drug conjugates
ADC payloads
Read more -
Peptide synthesis
Challenges in chemical and recombinant peptide production processes
Read more
-
Antibody production
Harness the Power of Single B Cell Antibody Technologies for Advanced Antibody Development
Read more -
Antibody production
Is Your Antibody Development Taking Too Long? Speed It Up with These Tips!
Read more -
Antibody production
How is VIPS Enhancing the Clone Selection Process in Therapeutic Antibody Production
Read more -
Antibody production
Top Tips for Extracting High-Performing Antibodies from Phage Display
Read more -
Antibody production
Mastering Hybridoma Technology: The Future of Monoclonal Antibodies in Research and Medicine
Read more
-
Antibody production
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists”
Read more -
Antibody production
Reinventing IgY biotherapeutics
Read more -
Antibody production
How the environment shapes immune system development during pregnancy
Read more -
Antibody production
“Cell-based phage display is helping us isolate more biologically relevant antibodies”
Read more -
Antibody production
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation”
Read more